These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 36701897

  • 1. D-beta-hydroxybutyrate reduced the enhanced cardiac microvascular endothelial FoxO1 to play protective roles in diabetic rats and high glucose-stimulated human cardiac microvascular endothelial cells.
    Zhang F, Wang S, Zhao C, Jiang D, Wang Y, Qi J, Li Y.
    Tissue Cell; 2023 Apr; 81():102031. PubMed ID: 36701897
    [Abstract] [Full Text] [Related]

  • 2. β-Hydroxybutyrate inhibits histone deacetylase 3 to promote claudin-5 generation and attenuate cardiac microvascular hyperpermeability in diabetes.
    Li B, Yu Y, Liu K, Zhang Y, Geng Q, Zhang F, Li Y, Qi J.
    Diabetologia; 2021 Jan; 64(1):226-239. PubMed ID: 33106900
    [Abstract] [Full Text] [Related]

  • 3. β-Hydroxybutyrate inhibits cardiac microvascular collagen 4 accumulation by attenuating oxidative stress in streptozotocin-induced diabetic rats and high glucose treated cells.
    Qi H, Gu L, Xu D, Liu K, Zhou M, Wang Y, Wang X, Li Y, Qi J.
    Eur J Pharmacol; 2021 May 15; 899():174012. PubMed ID: 33727057
    [Abstract] [Full Text] [Related]

  • 4. LncRNA DANCR deficiency promotes high glucose-induced endothelial to mesenchymal transition in cardiac microvascular cells via the FoxO1/DDAH1/ADMA signaling pathway.
    Wu M, Li T, Li G, Niu B, Wu T, Yan L, Wang S, He S, Huang C, Tong W, Li N, Jiang J.
    Eur J Pharmacol; 2023 Jul 05; 950():175732. PubMed ID: 37116560
    [Abstract] [Full Text] [Related]

  • 5. The role of FoxO1 in interleukin-1β-induced autostimulation in retina endothelial cells and retinas of diabetic rats.
    Wu L, Guo F, Wu Y, Wang Q, Ma X, Zhao Y, Qin G.
    Microvasc Res; 2017 Jul 05; 112():93-100. PubMed ID: 28283331
    [Abstract] [Full Text] [Related]

  • 6. High glucose decreases claudins-5 and -11 in cardiac microvascular endothelial cells: Antagonistic effects of tongxinluo.
    Li B, Li Y, Liu K, Wang X, Qi J, Wang B, Wang Y.
    Endocr Res; 2017 Feb 05; 42(1):15-21. PubMed ID: 27111519
    [Abstract] [Full Text] [Related]

  • 7. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats.
    Behl Y, Krothapalli P, Desta T, Roy S, Graves DT.
    Diabetes; 2009 Apr 05; 58(4):917-25. PubMed ID: 19168598
    [Abstract] [Full Text] [Related]

  • 8. β-hydroxybutyrate antagonizes aortic endothelial injury by promoting generation of VEGF in diabetic rats.
    Wu X, Miao D, Liu Z, Liu K, Zhang B, Li J, Li Y, Qi J.
    Tissue Cell; 2020 Jun 05; 64():101345. PubMed ID: 32473710
    [Abstract] [Full Text] [Related]

  • 9. Tongxinluo Reverses the Hypoxia-suppressed Claudin-9 in Cardiac Microvascular Endothelial Cells.
    Liu K, Wang XJ, Li YN, Li B, Qi JS, Zhang J, Wang Y.
    Chin Med J (Engl); 2016 Feb 20; 129(4):442-7. PubMed ID: 26879018
    [Abstract] [Full Text] [Related]

  • 10. Microvascular Barrier Protection by microRNA-183 via FoxO1 Repression: A Pathway Disturbed in Neuropathy and Complex Regional Pain Syndrome.
    Reinhold AK, Salvador E, Förster CY, Birklein F, Rittner HL.
    J Pain; 2022 Jun 20; 23(6):967-980. PubMed ID: 34974173
    [Abstract] [Full Text] [Related]

  • 11. MiR-181c restrains nitration stress of endothelial cells in diabetic db/db mice through inhibiting the expression of FoxO1.
    Yang G, Wu Y, Ye S.
    Biochem Biophys Res Commun; 2017 Apr 22; 486(1):29-35. PubMed ID: 28223216
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. FoxO1 inhibits autophagosome-lysosome fusion leading to endothelial autophagic-apoptosis in diabetes.
    Zhang H, Ge S, He K, Zhao X, Wu Y, Shao Y, Wu X.
    Cardiovasc Res; 2019 Dec 01; 115(14):2008-2020. PubMed ID: 30689742
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis.
    Zhang M, Sui W, Xing Y, Cheng J, Cheng C, Xue F, Zhang J, Wang X, Zhang C, Hao P, Zhang Y.
    Theranostics; 2021 Dec 01; 11(18):8624-8639. PubMed ID: 34522203
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Liraglutide ameliorates early renal injury by the activation of renal FoxO1 in a type 2 diabetic kidney disease rat model.
    Chen P, Shi X, Xu X, Lin Y, Shao Z, Wu R, Huang L.
    Diabetes Res Clin Pract; 2018 Mar 01; 137():173-182. PubMed ID: 29355652
    [Abstract] [Full Text] [Related]

  • 20. High glucose upregulates osteopontin expression by FoxO1 activation in macrophages.
    Zhang Q, Wang C, Tang Y, Zhu Q, Li Y, Chen H, Bao Y, Xue S, Sun L, Tang W, Chen X, Shi Y, Qu L, Lu B, Zheng J.
    J Endocrinol; 2019 Aug 01; 242(2):51-64. PubMed ID: 31096186
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.